Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Mol Genet Metab. 2018 May 7;124(3):204–209. doi: 10.1016/j.ymgme.2018.05.001

Figure 2. Deoxysphingolipids in patients with PSDs.

Figure 2

DoxDHCer species as measured by peak area ratio compared to internal standard were significantly elevated in individuals with PSD (n=2) compared to controls (n=12). a) DoxDHCer (m18:0), b) DoxDHCer (m20:0) c) DoxDHCer (m22:0). DoxDhCer, deoxydihydroceramide.